Breast |
Pro-tumorigenic |
Unknown |
Shorter patient survival |
Brglez et al. 2014 [92] |
Colon |
Pro/Anti-tumorigenic |
Increased cell proliferation |
Unknown |
Avoranta et al. 2010 [93] |
Gastric |
Anti-tumorigenic |
Reduction in cell migration and invasiveness |
Longer patient survival, less frequent metastasis |
Wang et al. 2013 [94] |
Lung |
Pro-tumorigenic |
Increased cell proliferation, lower rates of apoptosis |
Shorter patient survival |
Yu et al. 2012 [95] |
Oesophageal |
Pro-tumorigenic |
Increased cell proliferation |
Unknown |
Menschikowski et al. 2013 [96] |
Prostate |
Pro-tumorigenic |
Increased cell proliferation |
Shorter patient survival |
Oleksowicz et al. 2012 [97] |